使用前瞻性德国血管队列研究对OAC3-PAD风险评分预测大出血事件进行外部验证 - Suppr

External Validation of the OAC3-PAD Risk Score to Predict Major Bleeding Events Using the Prospective GermanVasc Cohort Study.

作者信息

Peters Frederik, Behrendt Christian-Alexander

机构信息

Department of Vascular Medicine, Research Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Eur J Vasc Endovasc Surg. 2022 Oct;64(4):429-430. doi: 10.1016/j.ejvs.2022.07.055. Epub 2022 Aug 8.

DOI:10.1016/j.ejvs.2022.07.055

PMID:35952908

Abstract

摘要

相似文献

External Validation of the OAC3-PAD Risk Score to Predict Major Bleeding Events Using the Prospective GermanVasc Cohort Study.

Eur J Vasc Endovasc Surg. 2022 Oct;64(4):429-430. doi: 10.1016/j.ejvs.2022.07.055. Epub 2022 Aug 8.

Nationwide Study in France To Predict One Year Major Bleeding and Validate the OAC3-PAD Score in Patients Undergoing Revascularisation for Lower Extremity Arterial Disease.

Eur J Vasc Endovasc Surg. 2023 Aug;66(2):213-219. doi: 10.1016/j.ejvs.2023.04.026. Epub 2023 Apr 28.

The OAC-PAD Risk Score Predicts Major Bleeding Events one Year after Hospitalisation for Peripheral Artery Disease.

Eur J Vasc Endovasc Surg. 2022 Mar;63(3):503-510. doi: 10.1016/j.ejvs.2021.12.019. Epub 2022 Feb 4.

The prospective GermanVasc cohort study.

Vasa. 2021 Nov;50(6):446-452. doi: 10.1024/0301-1526/a000966. Epub 2021 Jul 19.

Rationale and methods of the IDOMENEO health outcomes of the peripheral arterial disease revascularisation study in the GermanVasc registry.

Vasa. 2018 Oct;47(6):499-505. doi: 10.1024/0301-1526/a000730. Epub 2018 Aug 16.

Bleeding Risk Profile in Patients With Symptomatic Peripheral Artery Disease.

J Endovasc Ther. 2016 Jun;23(3):468-71. doi: 10.1177/1526602816637621. Epub 2016 Mar 11.

A New Preprocedural Score to Predict Bleeding Complications of Endovascular Interventions for Peripheral Artery Disease.

J Endovasc Ther. 2019 Dec;26(6):816-825. doi: 10.1177/1526602819866191. Epub 2019 Aug 5.

Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.

Catheter Cardiovasc Interv. 2020 Sep 1;96(3):E377-E386. doi: 10.1002/ccd.28642. Epub 2019 Dec 5.

Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).

Circ Cardiovasc Interv. 2017 Mar;10(3). doi: 10.1161/CIRCINTERVENTIONS.116.004904.

Clinical characteristics and outcomes of COMPASS eligible patients in France. An analysis from the REACH Registry.

Ann Cardiol Angeiol (Paris). 2020 Oct;69(4):158-166. doi: 10.1016/j.ancard.2020.07.002. Epub 2020 Aug 7.

引用本文的文献

Artificial intelligence in atherosclerotic disease: Applications and trends.

Front Cardiovasc Med. 2023 Jan 19;9:949454. doi: 10.3389/fcvm.2022.949454. eCollection 2022.

Antithrombotic Treatment Patterns of Patients with Symptomatic Peripheral Arterial Occlusive Disease in Germany: Evidence from Health Insurance Claims Data.

J Clin Med. 2022 Sep 16;11(18):5455. doi: 10.3390/jcm11185455.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

External Validation of the OAC3-PAD Risk Score to Predict Major Bleeding Events Using the Prospective GermanVasc Cohort Study.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献